Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer Article Swipe
Akihiro Tamiya
,
Mitsuo Osuga
,
Daijiro Harada
,
Shun‐ichi Isa
,
Yoshihiko Taniguchi
,
Keiichi Nakamura
,
Yasuyuki Mizumori
,
Tsutomu Shinohara
,
Hidetoshi Yanai
,
Katsumi Nakatomi
,
Masahide Oki
,
Masahide Mori
,
Tomohito Kuwako
,
Masahiko Ando
,
Koji Yamazaki
,
Atsuhisa Tamura
,
Yasuhiro Koh
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4854264
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4854264
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- http://doi.org/10.2139/ssrn.4854264
- OA Status
- green
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4399573525
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4399573525Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2139/ssrn.4854264Digital Object Identifier
- Title
-
Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-01Full publication date if available
- Authors
-
Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun‐ichi Isa, Yoshihiko Taniguchi, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Masahiko Ando, Koji Yamazaki, Atsuhisa Tamura, Yasuhiro KohList of authors in order
- Landing page
-
https://doi.org/10.2139/ssrn.4854264Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.2139/ssrn.4854264Direct OA link when available
- Concepts
-
Osimertinib, Lung cancer, Medicine, Oncology, Correlation, Cancer research, Internal medicine, Cancer, Mathematics, Adenocarcinoma, ROS1, GeometryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4399573525 |
|---|---|
| doi | https://doi.org/10.2139/ssrn.4854264 |
| ids.doi | https://doi.org/10.2139/ssrn.4854264 |
| ids.openalex | https://openalex.org/W4399573525 |
| fwci | |
| type | preprint |
| title | Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9990000128746033 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Lung Cancer Treatments and Mutations |
| topics[1].id | https://openalex.org/T10274 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9846000075340271 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Synthesis and biological activity |
| topics[2].id | https://openalex.org/T11845 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9660000205039978 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Cancer therapeutics and mechanisms |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777626846 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9615284204483032 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q21506464 |
| concepts[0].display_name | Osimertinib |
| concepts[1].id | https://openalex.org/C2776256026 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6947948932647705 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[1].display_name | Lung cancer |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5219135284423828 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.47839605808258057 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C117220453 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4536643624305725 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q5172842 |
| concepts[4].display_name | Correlation |
| concepts[5].id | https://openalex.org/C502942594 |
| concepts[5].level | 1 |
| concepts[5].score | 0.422870934009552 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[5].display_name | Cancer research |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4206851124763489 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.27765658497810364 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| concepts[8].id | https://openalex.org/C33923547 |
| concepts[8].level | 0 |
| concepts[8].score | 0.11422863602638245 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[8].display_name | Mathematics |
| concepts[9].id | https://openalex.org/C2781182431 |
| concepts[9].level | 3 |
| concepts[9].score | 0.08948233723640442 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q356033 |
| concepts[9].display_name | Adenocarcinoma |
| concepts[10].id | https://openalex.org/C2775999482 |
| concepts[10].level | 4 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q18031208 |
| concepts[10].display_name | ROS1 |
| concepts[11].id | https://openalex.org/C2524010 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q8087 |
| concepts[11].display_name | Geometry |
| keywords[0].id | https://openalex.org/keywords/osimertinib |
| keywords[0].score | 0.9615284204483032 |
| keywords[0].display_name | Osimertinib |
| keywords[1].id | https://openalex.org/keywords/lung-cancer |
| keywords[1].score | 0.6947948932647705 |
| keywords[1].display_name | Lung cancer |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5219135284423828 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.47839605808258057 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/correlation |
| keywords[4].score | 0.4536643624305725 |
| keywords[4].display_name | Correlation |
| keywords[5].id | https://openalex.org/keywords/cancer-research |
| keywords[5].score | 0.422870934009552 |
| keywords[5].display_name | Cancer research |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.4206851124763489 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/cancer |
| keywords[7].score | 0.27765658497810364 |
| keywords[7].display_name | Cancer |
| keywords[8].id | https://openalex.org/keywords/mathematics |
| keywords[8].score | 0.11422863602638245 |
| keywords[8].display_name | Mathematics |
| keywords[9].id | https://openalex.org/keywords/adenocarcinoma |
| keywords[9].score | 0.08948233723640442 |
| keywords[9].display_name | Adenocarcinoma |
| language | en |
| locations[0].id | doi:10.2139/ssrn.4854264 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210172589 |
| locations[0].source.issn | 1556-5068 |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1556-5068 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | SSRN Electronic Journal |
| locations[0].source.host_organization | https://openalex.org/I1318003438 |
| locations[0].source.host_organization_name | RELX Group (Netherlands) |
| locations[0].source.host_organization_lineage | https://openalex.org/I1318003438 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | http://doi.org/10.2139/ssrn.4854264 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5011822413 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Akihiro Tamiya |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Akihiro Tamiya |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5108911031 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Mitsuo Osuga |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mitsuo Osuga |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5005445917 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5314-2489 |
| authorships[2].author.display_name | Daijiro Harada |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Daijiro Harada |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5112241933 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Shun‐ichi Isa |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Shun-ichi Isa |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5013472489 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6387-3683 |
| authorships[4].author.display_name | Yoshihiko Taniguchi |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yoshihiko Taniguchi |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5034463390 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Keiichi Nakamura |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Keiichi Nakamura |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5051759863 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4134-2600 |
| authorships[6].author.display_name | Yasuyuki Mizumori |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yasuyuki Mizumori |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5076998048 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Tsutomu Shinohara |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tsutomu Shinohara |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5029047565 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Hidetoshi Yanai |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Hidetoshi Yanai |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5053684991 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Katsumi Nakatomi |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Katsumi Nakatomi |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5102864898 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Masahide Oki |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Masahide Oki |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5109424750 |
| authorships[11].author.orcid | https://orcid.org/0009-0007-9223-3854 |
| authorships[11].author.display_name | Masahide Mori |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Masahide Mori |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5076105654 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Tomohito Kuwako |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Tomohito Kuwako |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5076545273 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-2891-5424 |
| authorships[13].author.display_name | Masahiko Ando |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Masahiko Ando |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5009084626 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-2025-6268 |
| authorships[14].author.display_name | Koji Yamazaki |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Koji Yamazaki |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5051423202 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-8648-2191 |
| authorships[15].author.display_name | Atsuhisa Tamura |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Atsuhisa Tamura |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5054386489 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-8758-8980 |
| authorships[16].author.display_name | Yasuhiro Koh |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Yasuhiro Koh |
| authorships[16].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.2139/ssrn.4854264 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9990000128746033 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Lung Cancer Treatments and Mutations |
| related_works | https://openalex.org/W3184060414, https://openalex.org/W3112920278, https://openalex.org/W3139019175, https://openalex.org/W2582477737, https://openalex.org/W3136829214, https://openalex.org/W4206580764, https://openalex.org/W4294935045, https://openalex.org/W3205941621, https://openalex.org/W4388045361, https://openalex.org/W2772985786 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.2139/ssrn.4854264 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210172589 |
| best_oa_location.source.issn | 1556-5068 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1556-5068 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | SSRN Electronic Journal |
| best_oa_location.source.host_organization | https://openalex.org/I1318003438 |
| best_oa_location.source.host_organization_name | RELX Group (Netherlands) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.2139/ssrn.4854264 |
| primary_location.id | doi:10.2139/ssrn.4854264 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210172589 |
| primary_location.source.issn | 1556-5068 |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1556-5068 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | SSRN Electronic Journal |
| primary_location.source.host_organization | https://openalex.org/I1318003438 |
| primary_location.source.host_organization_name | RELX Group (Netherlands) |
| primary_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | http://doi.org/10.2139/ssrn.4854264 |
| publication_date | 2024-01-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6800000071525574 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.19372691 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |